LifeMD, Inc.

Total Valuation

LifeMD, Inc. carries a market capitalization of 233.11M, placing it among publicly traded companies globally. Its enterprise value stands at 138.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

LifeMD, Inc. currently has 47.53M shares outstanding.

Valuation Ratios

LifeMD, Inc. trades at a trailing price-to-earnings ratio of 79.22. The price-to-sales ratio is 0.93, and the price-to-book ratio stands at -0.70.

Enterprise Valuation

On an enterprise value basis, LifeMD, Inc. trades at an EV/EBITDA multiple of 316.36 and an EV/FCF ratio of 16.77. The EV/Sales ratio of 0.77 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 435.27 provides insight into valuation relative to core operating earnings.

Financial Position

LifeMD, Inc. maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.05, indicating elevated leverage, while an interest coverage ratio of -14.18 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

LifeMD, Inc.'s stock has declined approximately -64.50663% over the past 52 weeks. The 50-day moving average sits at 4.46, while the 200-day moving average is 4.46.

Income Statement

Over the trailing twelve months, LifeMD, Inc. generated 179.63M in revenue and converted that into 5.21M in net income, yielding earnings per share of -0.43. EBITDA reached -10.42M, while operating income came in at -18.03M.

Balance Sheet

LifeMD, Inc. holds 34.48M in cash and equivalents against 6.17M in total debt, resulting in a net debt position of -34.48M. Total book value stands at -237.78M, with working capital of 2.11M providing operational flexibility.

Cash Flow

LifeMD, Inc. produced 5.66M in operating cash flow over the past twelve months. After subtracting -1.86M in capital expenditures, free cash flow totaled 3.80M - equivalent to 0.08 per share.

Margins

LifeMD, Inc. operates with a gross margin of 86.08, reflecting its pricing power and cost economics. The operating margin of -10.04 and net profit margin of 2.90 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

LifeMD, Inc.'s most recent stock split took place on October 14, 2020 with a 5:1 split ratio.

Scores

LifeMD, Inc. posts an Altman Z-Score of -1.76, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.